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1Laboratory of Molecular Physiology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MarylandABSTRACT Between 8 to 14 calcium-calmodulin (Ca2þ/CaM) dependent protein kinase-II (CaMKII) subunits form a complex
that modulates synaptic activity. In living cells, the autoinhibited holoenzyme is organized as catalytic-domain pairs distributed
around a central oligomerization-domain core. The functional significance of catalytic-domain pairing is not known. In a provoc-
ative model, catalytic-domain pairing was hypothesized to prevent ATP access to catalytic sites. If correct, kinase-activity would
require catalytic-domain pair separation. Simultaneous homo-FRET and fluorescence correlation spectroscopy was used to
detect structural changes correlated with kinase activation under physiological conditions. Saturating Ca2þ/CaM triggered
Threonine-286 autophosphorylation and a large increase in CaMKII holoenzyme hydrodynamic volume without any appreciable
change in catalytic-domain pair proximity or subunit stoichiometry. An alternative hypothesis is that two appropriately positioned
Threonine-286 interaction-sites (T-sites), each located on the catalytic-domain of a pair, are required for holoenzyme interac-
tions with target proteins. Addition of a T-site ligand, in the presence of Ca2þ/CaM, elicited a large decrease in catalytic-domain
homo-FRET, which was blocked by mutating the T-site (I205K). Apparently catalytic-domain pairing is altered to allow T-site
interactions.INTRODUCTIONCalcium-calmodulin dependent protein kinase-II (CaMKII)
is a highly abundant neuronal kinase involved in regulating
synaptic efficacy (1,2). The functional holoenzyme is
comprised of 8 to 14 subunits (3). There are four major iso-
forms of CaMKII (a, b, g, and d) with each subunit having a
C-terminal oligomerization domain and an N-terminal cata-
lytic-domain connected by a regulatory domain and a vari-
able length linker. Synaptic activity gates calcium influx
into synaptic terminals that manifest as transient spikes of
high intracellular calcium concentrations. In the brain, the
frequency of calcium spikes is thought to encode informa-
tion, and CaMKII is thought to serve as a calcium spike fre-
quency decoder (2). The mechanism by which CaMKII
detects the frequency of calcium spikes is thought to arise
from coordinated interactions between adjacent CaMKII
subunits in the holoenzyme (4). During these spikes calcium
ions bind to calmodulin to form Ca2þ/Calmodulin (Ca2þ/
CaM). In turn, Ca2þ/CaM binds to the regulatory domain
of CaMKII to activate the kinase (5). Adjacent to the
Ca2þ/CaM-binding site is an autoinhibitory pseudo-sub-
strate segment that occludes the substrate-binding site
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0006-3495/15/05/2158/13 $2.00autoinhibitory segment (7,8). Each regulatory domain can
bind one molecule of Ca2þ/CaM. Mutations at the Ca2þ/
CaM-binding site (TT305/6DD in CaMKIIa) prevent CaM
binding and kinase activation (9,10). Adjoining the autoin-
hibitory segment is an additional regulatory domain site
that contains Threonine-286 (T286 in CaMKIIa numbering)
(11,12). In the autoinhibited holoenzyme T286 is thought to
be closely associated with a site on the catalytic-domain
called the T-site, and both sites are inaccessible (8,13).
The T-site mediates protein interactions between CaMKII
and a host of other proteins (14–21), in the brain most
notably with N-methyl-D-aspartate (NMDA) receptors. In-
teractions with the NMDA receptor is required for the
movement of the holoenzyme from dendritic shafts into
spines in response to synaptic activity (13,16,18,19,22,23),
and this translocation is thought to be essential for modu-
lating synaptic efficacy. Consequently, in addition to acti-
vating the kinase, Ca2þ/CaM binding destabilizes the
interaction of T286 with the T-site, allowing T286 to
become a kinase substrate, and the T-site to mediate holoen-
zyme interactions with other proteins (1,5). A T-site muta-
tion (I205K) increases Ca2þ/CaM affinity (24) and
prevents both activity dependent holoenzyme clustering
(25) and interactions with the NR2B subunit of NMDA re-
ceptors (13,16). The mechanism by which the I205K muta-
tion prevents these protein interactions is poorly understood.
An activated CaMKII subunit can covalently attach a
phosphate group to the T286 site of an adjacent subunit
(intra-holoenzyme autophosphorylation) (11,12,26) but
cannot autophosphorylate its own T286 site (27,28).http://dx.doi.org/10.1016/j.bpj.2015.03.028
Structural Changes in CaMKII Holoenzyme 2159Because T286 is inaccessible in the autoinhibited state (7),
T286 autophosphorylation requires the synchronized bind-
ing of two molecules of Ca2þ/CaM (29): one to activate
the kinase of one subunit, the other to unmask and present
as substrate an adjacent T286 to its activated neighbor.
Kinetic analysis reveals that T286 autophosphorylation,
and Ca2þ/CaM binding both show positive cooperativity
for Ca2þ/CaM (30), but the structural basis of how two
CaMKII subunits interact with Ca2þ/CaM and with each
other to allow T286 autophosphorylation is not understood.
The covalent addition of a phosphate group on T286
sterically prevents the reassociation of that regulatory
domain pseudo-substrate section with its catalytic-domain
(24). The most noted consequence of T286 autophosphory-
lation is that it produces a catalytic-domain whose kinase
activity remains persistently active (autonomy) even after
calcium concentrations return to basal levels (14,31–33).
The ability to enter into an autonomous state is thought to
be integral to its ability to sense calcium spike frequency
(1). T286 autophosphorylation is typically a fast reaction
(28), but virtually nothing is known about how the structure
of the intact CaMKII holoenzyme changes during T286
autophosphorylation.
The degree of positive cooperativity observed for Ca2þ/
CaM binding, T286 autophosphorylation, and for establish-
ing autonomy (30) all indicate that Ca2þ/CaM binding to
one subunit increases the probability for interactions with
neighboring subunits. This implies that subunit contact
surfaces within the holoenzyme are altered and could poten-
tially be monitored in response to activation. Four types
of CaMKII subunit interactions have been proposed for
the autoinhibited holoenzyme: interactions between oligo-
merization domains (7,34–36), regulatory domains (37),
catalytic-domains (7,38,39), and most recently a hybrid
interaction between catalytic- and oligomerization domains
(40). This last category, however, is limited to an extremely
compact form of the holoenzymewhere individual catalytic-
domains are docked directly to the central oligomerization-
domain hub without contacting catalytic- or regulatory
domains of other subunits (40). Because this novel interac-
tion is only observed in a mutated form of a rare splice
variant that is poorly activated by Ca2þ/CaM (41), it is un-
likely that its structure represents the prevailing form of the
holoenzyme that is readily activated by Ca2þ/CaM (30,42).
Furthermore, based on the paired catalytic-domain prox-
imity detected in living cells (38,39), data that are not
readily explained by this holoenzyme structural model
(40), a more plausible mechanism for cooperativity under
physiological conditions would be direct interaction be-
tween pairs of regulatory and/or catalytic-domains.
Direct interactions between regulatory domains have
been described (37), but its existence in the intact holoen-
zyme is controversial. Based on x-ray crystallography
modeling of crystals formed from C. elegans CaMKIIa
deletion mutants lacking oligomerization domains, autoin-hibited CaMKII catalytic-domains are thought to be orga-
nized as a collection of dimers distributed around the
central oligomerization-domain core (Fig. 1 A). Each dimer
is held together via a coiled-coil interaction surface
composed of the regulatory domains of two subunits (37).
In this provocative model catalytic-domain pairing occludes
ATP binding sites and thus prevents kinase activation. Ca2þ/
CaM binding to the regulatory domain directly disrupts the
regulatory-domain coiled-coil and therefore disrupts cata-
lytic-domain pairing (37). Evidence supporting and dis-
agreeing with this model exist. Homo-FRET (38) and
Hetero-FRET (39) analysis of cells expressing fluorescent
protein tagged holoenzyme attached to catalytic-domains
support paired catalytic-domains in the autoinhibited state.
Nevertheless, these experiments do not differentiate be-
tween pairing as a result of coiled-coil regulatory-domain
interactions from other interactions. Catalytic-domain
pairing was also observed in primary cultures of hippocam-
pal neurons, and as predicted, calcium influx through
NMDA receptors resulted in catalytic-domain separation
(38). Nonetheless, it is not clear from these in vivo ex-
periments if the separation of catalytic-domain pairs re-
sulted directly from the binding of Ca2þ/CaM to the
CaMKII regulatory domain, or if it arose from subsequent
events (1,16).
In contrast to the C. elegans CaMKII coiled-coil struc-
ture, x-ray analysis of several isoforms of human CaMKII
failed to identify any conserved dimer interface between
regulatory domains (7). These studies used subunits with
deleted oligomerization domains and, therefore, may not
accurately represent structures found in the intact holoen-
zyme. It is known that when the oligomerization domain
of CaMKII is deleted, the enzyme becomes monomeric un-
der physiological concentrations (35,36,38), cooperativity is
lost (43), and it no longer translocates into spines (13,18).
Analytical ultracentrifugation analysis of the human
CaMKII oligomerization-domain deletion-mutants did
reveal that dimers could form in solution, but with
extremely low affinity (KD of 200 to 600 mM) (7). Nonethe-
less, in the context of a holoenzyme, where the effective
concentrations of catalytic-domains are high, dimers would
be expected to form (7). Surprisingly, in these studies, incu-
bation with competitive regulatory-domain peptide did not
perturb pairing (7), again raising doubts that a regulatory
domain coiled-coil structure is responsible for pairing. An
alternative hypothesis is that T-sites stabilize catalytic-
domain pairing within the context of the autoinhibited holo-
enzyme. This hypothesis allows catalytic-domains to remain
paired both before and after activation readily explaining
Hill coefficients with values near 2 for Ca2þ/CaM binding
and T286 autophosphorylation. It can also rationalize the
speed and efficiency of T286 autophosphorylation if cata-
lytic-domain pair activation with Ca2þ/CaM orients the
kinase substrate-site of one subunit with the T286 site of
the other (7). To differentiate between these models,Biophysical Journal 108(9) 2158–2170
FIGURE 1 Activation of Venus-tagged
CaMKIIa. (A) Cartoon depicting structural changes
of autoinhibited CaMKII holoenzyme activation by
Ca2þ/CaM binding based on the coiled-coil cata-
lytic-domain pairing model. Gray, cyan, yellow,
and green shapes represent association domains,
catalytic-domains, regulatory domains, and Ca2þ/
CaM, respectively. To monitor structural changes
of CaMKIIa, a Venus molecule is attached to
the N-terminal catalytic-domain (not shown
in this cartoon). (B) Venus-tagged CaMKIIa
(V-CaMKIIa) activity (characterized by TAMRA-
Autocamtide-3 phosphorylation) measured using
a fluorescence anisotropy based binding assay,
IMAP-FP. Data are plotted as mean5 SD, n ¼ 5.
Black dashed line represents fitting of dose
response curve. (C) Immunoblots of V-CaMKIIa,
incubatedwith variousCaMconcentrations, probed
using either GFP or phospho-Threonine-286
(pT286) specific antibody. (D) CaM dependent
changes in T286 autophosphorylation based on
the densitometric ratio between the amount of
T286 phosphorylated V-CaMKIIa (probed with
anti-pT286) and total V-CaMKIIa (probed with
anti-GFP). These values were determined from im-
munoblots such as shown in (C). Data are plotted as
mean 5 SD, n ¼ 3. Values are normalized to the
mean ratio at CaM concentration of 2.5 mM. Red
dashed line highlights the change in T286 auto-
phosphorylation. Note that the V-CaMKIIa con-
centration is ~100 times higher in (D) than in (B).
To see this figure in color, go online.
2160 Nguyen et al.fluorescence polarization and fluctuation analysis (FPFA), a
photometry technique that combines homo-FRET and fluo-
rescence correlation spectroscopy (FCS) (39) was used to
determine how the structure of the intact CaMKII holoen-
zyme changes on activation with Ca2þ/CaM followed by
subsequent T286 autophosphorylation and binding to a
T-site ligand.TABLE 1 Primer pairs for site directed mutagenesis
TT305/
306DD
sense 50-GGAGCCATCCTCGACGACATGCTGGCCAC
CAGG-30
antisense 50-CCTGGTGGCCAGCATGTCGTCGAGGAT
GGCTCC-30
T286A sense 50-ATGCACAGACAGGAGGCCGTGGACTGC
CTGA-30
antisense 50-TCAGGCAGTCCACGGCCTCCTGTCTGT
GCAT-30
K42R sense 50- AGTATGCTGCCAGGATTATCAACAC-30
antisense 50-GTGTTGATAATCCTGGCAGCATACT-30
I205K sense 50-TCATCCTGTATAAGTTGCTGGTTGG-30
antisense 50-CCAACCAGCAACTTATACAGGATGA-30MATERIALS AND METHODS
Cell culture, transfection, and homogenate
preparation
All experiments were performed with HEK 293 cells (ATCC, Ocean
Biologics, Seattle, WA). Details of the cell culture, transfection, and
homogenate preparation has been published elsewhere (39). In some exper-
iments, homogenates with expressed Venus-tagged constructs (holoenzyme
assembly concentration varies from 15 to 40 nM) were first incubated with
either calmodulin (2.5 mM, Ocean Biologics) in activation buffer (0.1 mM
ATP, 0.1 mM CaCl2, 1X KinEASETM buffer, 5 mM MgCl2, 10 mM DTT,
all from EMD Millipore, Billerica, MA), and 0.01% Brij-35 (Santa Cruz
Biotechnology, Dallas, TX) or with CaMKIINtide (1 mM, EMD), or a
mixture of both Ca2þ/CaM and CaMKIINtide for 90 to 120 min. For
live-cell imaging measurements, cells were transfected with various combi-
nations of DNA encoding V-CaMKIIa, CaM, and CaMKIIN (typically 1 mg
DNA/250,000 cells). Transfected cells were plated on 35 mm glass-bottom
dishes and incubated overnight in phenol-red free Dulbecco’s modified
Eagle’s media. The next day, the Dulbecco’s modified Eagle’s media was
replaced by Dulbecco’s phosphate-buffered saline buffer (1X, with calcium
and magnesium, Mediatech, Manassas, VA). The intracellular calcium con-Biophysical Journal 108(9) 2158–2170centration was raised by incubating cells with Ionomycin (1 mg/ml, Sigma
Aldrich, St. Louis, MO) for 30 min at room temperature. Images of the
cellular fluorescence were collected by a DCS-120 system either before
or after the incubation.Molecular biology
DNA clones encoding monomeric Venus (Addgene ID 27794), V17V
(Addgene ID 29424), V32V (Addgene ID 29561), and V-CaMKIIa
(Addgene ID 29428), and V-CaMKIIa(T286A) (Addgene ID 29430) are
available from Addgene (Cambridge, MA; http://www.addgene.org/
Steven_Vogel#). Mutations in V-CaMKIIa were introduced by site directed
mutagenesis polymerase chain reaction as previously described (38) using
the primer pairs shown in Table 1.
Construction of V-CaMKIIa(D344) and V-CaMKIIa(I205K/D344)
was accomplished by introducing a stop codon in V-CaMKIIa and
V-CaMKIIa(I205K), respectively, by site directed mutagenesis polymerase
Structural Changes in CaMKII Holoenzyme 2161chain reaction using primer pair Sense 50-CACCAAAGTGTAACGCAAA
CAGG-30 and antisense 50-CCTGTTTGCGTTACACTTTGGTG-30. Note
that the mutated bases are underlined in the primer sequences.
Human calmodulin (GB accession number NM_ 001743.4) cDNA was
subcloned into pCI Mammalian Expression Vector (Promega, Madison,
WI) using XhoI and SmaI restriction sites using primer pair sense
50-ATTCTCGAGCAGCATGGCTGACCAACTGACTG-30 and antisense
50-GGGGATATCTCACTTCGCTGTCATCATTTGTAC-30.
Mouse CaMKII inhibitors beta (NM_028420.2) cDNA was amplified
from mouse whole brain cDNA (Clontech, Mountain View, CA) and subcl-
oned into pCI (Clontech) or pVenusC1 mammalian expression vector
(Addgene Plasmid 27794) using Sal1 restriction sites using the primer
pair sense 50-GATCGATCGTCGACACCATGTCCGAGATCCTACCC
TACG-30 and antisense 50-GATCGATCGTCGACCTACACTCCGGACG
GAGGCTTC-30. All resulting CaMKIIa constructs were confirmed by
sequencing.CaMKII kinase activity assay
Substrate phosophorylation activity of Venus-tagged CaMKIIa was
measured using a 96-well format fluorescence polarization assay, IMAP-
FP (Molecular Devices, Sunnyvale, CA). Phosphorylation of TAMRA-
Autocamtide-3 (Molecular Devices) by the test kinase leads to high-affinity
interaction between the phosphorylated substrate and trivalent metal con-
taining nanoparticles (beads). This interaction results in slower rotational
motion of the phosphorylated peptides in solution and thus higher polariza-
tion/anisotropy values. Venus-tagged CaMKIIa subunit (0.2 to 0.3 nM) was
added to the assay mix (20 ml volume) containing 1X KinEASE buffer
(EMD Millipore; 10 mM DTT, 100 mM ATP, 100 mM CaCl2, 100 nM
TAMRA-Autocamtide-3, and varying concentrations of Calmodulin). The
assay mix was incubated at room temperature for 1 h Next, 80 ml of Binding
System (Molecular Devices), consisting of 1:600 dilution of Binding
Reagent containing the nanoparticles and Buffer A and Bmixed in 3:1 ratio,
was added to each assay mix and incubated at 37C for 1 h. The
fluorescence polarization of TAMRA-Autocamtide-3 was measured by
PHERAstar FS (BMG-Labtech, Cary, NC) spectrofluorimeter coupled
with a polarization cube FP-540-20, 590-20, 590-20 using 800 gain and
fixed slit size. Aqueous solution of Rose Bengal was run simultaneously
to determine the instrument g-factor. The raw values from the parallel
and perpendicular channels were corrected for background (using readings
from samples with no substrate) and steady-state anisotropy was calculated
using the following equation:
r ¼ III-gIt
III þ 2gIt;
where, r is the steady-state anisotropy, III and It are signals fromparallel and
perpendicular channels, respectively, and g is the instrumentation factor.Anisotropy values were plotted as the function of changing Calmodulin con-
centration and the curve was fit using variable slope dose-response model.
EC50 and Hill slope was calculated from the fit (Prism 6). Note that because
TAMRA concentrations were always at least two orders of magnitude
greater than Venus, and because filters used in this assay were designed to
isolate TAMRA excitations and emission, Venus fluorescence did not alter
TAMRA anisotropy measurements under these assay conditions.T286 immunoblot assay
Cell lysates containing either inactive or activated V-CaMKIIa, or
V-CaMKIIa(I205K) were used to measure T286 autophhosphorylation.
The sample concentration (holoenzyme concentration, 13 to 30 nM) was
adjusted to have comparable photon count rates (determined using
FPFA). Nonreducing sample loading buffer (Thermo, Inc., Waltham,
MA) and 100 mM dithiothreitol (DTT) were added to the samples andthe mix was heated at 90C for 5 min. The samples were loaded on tandem
7.5% Mini-PROTEAN TGX gel and blotted onto tandem polyvinylidene
difluoride membranes (110 V for 55 min). Next, one of the two blots were
probed with mouse monoclonal antibody against phosphoThreonine-286-
CaMKIIa antibody (Abcam, dilution 1:1000), whereas the second set was
probed with either a rabbit polyclonal antibody against green fluorescent
protein (GFP) (Abcam (Cambridge, MA), dilution 1:10,000), or with rabbit
polyclonal antibody against CaMKIIa (Sigma Aldrich C6974). Next,
primary antibodies were probed with either goat anti-mouse peroxidase con-
jugated secondary antibody (for phosphoThreonine-286-CaMKIIa primary
antibody, Thermo Scientific Cat. No. 32430, dilution 1:10,000), or Goat
Anti-Rabbit peroxidase conjugated secondary antibody (for Anti-GFP or
Anti-CaMKIIa primary antibodies, Thermo Scientific Cat. No. 32460,
dilution 1:10,000). The blots were then incubated in luminol solution
(SuperSignal West Femto Maximum Sensitivity substrate kit, Thermo Sci-
entific Cat. No. 34095) for 2 min following manufacturer’s instruction.
Next the blot was washed in Tris-buffered saline and images were taken in
a Kodak 4000R image station with an exposure of 5 to 10 min. Sixteen-bit
tiff images were used for densitometry in a customized program written in
Igor Pro Version-6.4 (Wavemetrics, Portland, OR) that subtracted the global
and local background around each band.Optical spectroscopic experimental setup
The FPFA experimental setup and validation had been described previously
(39). For live-cell fluorescence imaging, a DCS-120 scan head (Becker &
Hickl, Berlin, Germany) attached to the side port of an inverted microscope
(Zeiss Axio Observer, Thornwood, NY) and a Simple Tau 150 time-corre-
lated photon counting system (Becker & Hickl) were used to form a two-
photon laser-scanning microscope. In addition to the DCS-120’s original
components, a near-IR linear polarizer (100,000:1 extinction ratio,
Thorlabs, Newton, NJ) and a Zeiss 40-1.2 NA water objective were also
used for the excitation pathway. Note that all optics used in this pathway
were selected to minimize group delay dispersion. For the emission
pathway, two high-throughput band-pass filters (HQ 525/25, Chroma, Bel-
lows Falls, VT), two visible-range linear polarizers (100,000:1 extinction
ratio, Thorlabs), and two HPM-100-40 hybrid detectors (dark count rate
400 to 850 cps, Becker & Hickl) were employed for parallel and perpendic-
ular polarization channels. Similar to the FPFA setup, an 80-MHz, 200-fs
mode locked Ti:sapphire laser (Coherent, Inc. (Santa Clara, CA), Chame-
leon Ultra-2) was tuned to 950 nm to provide linearly polarized pulsed
two-photon excitation. SPCM software (Becker & Hickl) running in
FIFO imaging mode was used for the data acquisition. Excitation power
was kept low (~15 mW before the objective) to avoid bleaching during
acquisition (30 to 60 s). Cells expressing low levels of V-CaMKIIa fluores-
cence were selected to avoid nonspecific FRET arising from over expres-
sion. All measurements were performed at room temperature.Data analysis and calibration
Data analyses including time-resolved anisotropy, lifetime, polarized fluo-
rescence fluctuation analyses, and FPFA calibration have been described
elsewhere (39). The steady-state anisotropy of a sample was estimated
from FPFA data by using the following integral of parallel and perpendic-
ular lifetime decay channels:
r ¼
R
t
IIIðtÞ-g
R
t
ItðtÞ
R
t
IIIðtÞ þ 2g
R
t
ItðtÞ;
where IIIðtÞ and ItðtÞ are the fluorescence intensity decay of parallel and
perpendicular channels (dark noise subtracted), respectively, and g is the in-strument correction factor which for our microscope had a value of 1.125
as determined by calibration using fluorescein tail fitting. For live-cellBiophysical Journal 108(9) 2158–2170
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cein yielded a g-factor of 0.99. Steady-state anisotropy values at each pixel
(xy) was calculated using the following:
rðxyÞ ¼ IIIðxyÞ-gItðxyÞ
IIIðxyÞ þ 2gItðxyÞ;
where IIIðxyÞ and ItðxyÞ are the steady-state fluorescence intensity of par-
allel and perpendicular channels (dark noise subtracted), respectively. Simi-larly intensity images were calculated from parallel and perpendicular
intensity channels at each pixel using the following:
IðxyÞ ¼ IIIðxyÞ þ 2gItðxyÞ:Curve fitting and statistics
SPCM software (Becker & Hickl) was used to calculate auto- and cross-
correlation curves from macro-time data as well as time decay curves from
micro-time data. IGOR Pro software (V6.4, Wavemetrics) was used for
fitting of cross-correlation curves, and for calculating time-resolved and
steady-state anisotropy. GraphPad Prism 6 (La Jolla, CA) was used for
fitting of dose response curves and calculating the EC50 and Hill coeffi-
cient. Prism 6 was also used to calculate means, standard errors of the
mean, and standard deviations (SD) or medians and interquartile ranges
(IQR) for parametric or nonparametric statistical comparisons, respec-
tively. Values are presented throughout the text as mean 5 SD unless
otherwise noted, and deviation of 5 0.00 indicates a value of less than
0.005. Furthermore, Prism 6 was used to calculate an analysis of variance
(ANOVA) test using Tukey’s multiple comparison (for parametric statisti-
cal comparisons) or a Kruskal-Wallis test using Dunn’s multiple compar-
ison (for nonparametric statistical comparisons) to compare individual
values within a data set.FIGURE 2 Structural changes associated with CaMKII activation
observed by FPFA. (A) Brightness (number of photon count per molecule
per second), (B) diffusion time, (C) steady-state anisotropy, and (D) time-
resolved anisotropy (TRA) of V-CaMKIIa and V-CaMKIIa(TT305/
306DD) (a mutant that does not bind to Ca2þ/CaM) either alone or incu-
bated with saturating Ca2þ/CaM. Bars represent the means with n ¼ 5.
Dashed lines indicate the baseline signal of the autoinhibited holoenzyme
before activation. To see this figure in color, go online.RESULTS
Validation of V-CaMKIIa
Twenty-four hours after transfection with DNA encoding
Venus-CaMKIIa (V-CaMKIIa) where the Venus molecule
was tagged to the N-terminal catalytic-domain (Fig. S1 in
the Supporting Material) (38,39), cells were harvested and
homogenates prepared for analysis. FCS measurements
were used to adjust the V-CaMKIIa subunit concentration
to between 0.2 to 0.3 nM and CaMKII activity was
measured using a TAMRA-autocamtide3 anisotropy assay.
V-CaMKIIa had an EC50 value for calmodulin of 2.0 5
0.4 nM and a Hill coefficient of 1.65 0.5 (Fig. 1 B). Immu-
noblot analysis revealed a fluorescent protein-like epitope in
these homogenates migrating at 80 kDa, the expected mo-
lecular weight of Venus-tagged CaMKIIa (Fig. 1 C, top),
as well as an 80 kDa phospho-T286 epitope whose abun-
dance represents the extent of T-286 autophosphorylation.
The latter increased with CaM concentration (Fig. 1 C,
bottom). The relationship between CaM concentration and
T286 autophosphorylation is plotted in Fig. 1 D. Immuno-
capillary electrophoresis demonstrated that endogenous
CaMKIIa levels in HEK cells were too low to be detected,
and indicated that exogenously expressed V-CaMKIIa was
not degraded to form untagged CaMKIIa (Fig. S2, A
and B). Because V-CaMKIIa responds to Ca2þ/CaM coop-Biophysical Journal 108(9) 2158–2170eratively at nanomolar concentrations to phosphorylate
an exogenous substrate similarly to native CaMKIIa
(Fig. S2 C), can autophosphorylate T286 in response to
activation, and assembles to form the holoenzyme (39),
we conclude that the V-CaMKIIa is a valid model for study-
ing conformational changes associated with holoenzyme
activation.Holoenzyme structural changes associated with
activation
FPFA simultaneously monitors molecular brightness (a
measure of the number of fluorescent subunits in a com-
plex), diffusion time (an attribute sensitive to the hydrody-
namic volume of a protein complex), and time-resolved
anisotropy (TRA; indicative of homo-FRET, and hence
proximity, between Venus-tagged subunits) (39). FPFA
measurements were performed on homogenates of cells ex-
pressing V-CaMKIIa incubated with or without saturating
Ca2þ/CaM. The CaM binding-site mutant TT305/306DD
was used as a negative control. Similar brightness values
were obtained for all samples (Fig. 2 A). As these values
were not statistically different (Kruskal-Wallis test, P ¼
0.6350), we conclude that Ca2þ/CaM does not alter holoen-
zyme subunit stoichiometry. On the other hand, there was a
Structural Changes in CaMKII Holoenzyme 2163significant increase in V-CaMKIIa diffusion time (which is
sensitive to holoenzyme hydrodynamic volume) with Ca2þ/
CaM activation (Tukey’s comparison test; Fig. 2 B). In
contrast, the negative control did not change. Surprisingly,
holoenzyme activation was not detected by steady-state
anisotropy (Fig. 2 C, Kruskal-Wallis test P ¼ 0.8964) or
TRA (Fig. 2 D), suggesting that activation by Ca2þ/CaM
does not perturb catalytic-domain pairing. Thus, an increase
of holoenzyme hydrodynamic volume is associated with
activation.
Limiting CaM concentration was next used to identify
structural intermediates correlated with partial activation.
Under these conditions holoenzyme brightness was again
unaltered (Fig. 3 A). In contrast, a small biphasic anisotropy
response was now detected (Fig. 3 B), whereas holoenzyme
diffusion time increased monotonically with added Ca2þ/
CaM (Fig. 3 C). CaM dependent changes in T286 autophos-
phorylation paralleled the diffusion-time dose-response
(Fig. 1 D) and are replotted for comparison (Fig. 3 C).
The biphasic anisotropy response implies that when only
one subunit in a pair is activated catalytic-domain pair orga-
nization is perturbed.
To investigate the structural basis of these intermediates,
we perturbed T286 autophosphorylation by 1) removingFIGURE 3 Structural intermediates associated with CaMKII activation obser
state anisotropy, and (C) diffusion time of V-CaMKIIa and V-CaMKIIa(TT305/
are mean5 SD, n¼ 4. Dashed lines in (A) are for eye guiding. Venus dimer anis
as dashed lines in (B). In (C), CaM dependent changes of T286 autophosphoryla
autophosphorylation was explored by observing structural changes in the holoen
alytic activity (V-CaMKIIa(K42R)), or by introducing a mutation that lacks the T
changes of (D) normalized brightness, (E) steady-state anisotropy, and (F) diff
mean 5 standard error of the mean, n ¼ 4. To see this figure in color, go onlinATP, 2) using a mutant that lacks catalytic activity (K42R)
(44), or 3) using a mutant that lacks the T286 autophosphor-
ylation site (T286A) (12). Data from Fig. 3 A are replotted
as normalized brightness indicating that ~10 Venus-tagged
subunits comprise the holoenzyme (Fig. 3 D) as previously
reported (39). Normalized brightness values in the absence
of ATP, for the K42R and T286A mutants were measured,
all were indistinguishable (ANOVA; p ¼ 0.2441). To inves-
tigate the biphasic V-CaMKIIa anisotropy response, Ca2þ/
CaM-dependent changes of V-CaMKIIa anisotropy was
measured in the absence of ATP. Now anisotropy increased
monotonically (Fig. 3 E). A similar change was observed for
the K42R mutant but with signs of recovery at high CaM
concentrations. Addition of CaM to V-CaMKIIa(T286A)
triggered a large dose-dependent increase in anisotropy
(Fig. 3 E). Even in the absence of CaM, T286A always dis-
played elevated anisotropy values (Fig. 3 E). In Fig. 3 F,
data from Fig. 3 C were transformed into diffusion
coefficients and compared with diffusion coefficients for
V-CaMKIIa in the absence of ATP, and for the K42R and
T286A mutants. The diffusion coefficients for all samples
decreased with increased CaM concentration except for
V-CaMKIIa(TT305/306DD). This drop was greatest for
wild-type holoenzyme. It was attenuated in the absence ofved by FPFA. Ca2þ/CaM dependent changes of (A) brightness, (B) steady-
306DD) were monitored under conditions of limiting CaM. Data in (A)–(C)
otropy controls with 17 (V17V) or 32 (V32V) amino-acid linkers are shown
tion from Fig. 1 D is replotted for comparison. Next, the influence of T286
zyme triggered by removing ATP, by introducing a mutation that lacks cat-
286 autophosphorylation site (V-CaMKIIa(T286A)). Ca2þ/CaM dependent
usion coefficient were plotted for the above mutants. Data in (D)–(F) are
e.
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2164 Nguyen et al.ATP, and in the mutants that either lacked catalytic activity,
or the T286 kinase substrate. Interestingly, T286A displayed
the smallest change in diffusion coefficient and the
largest change in anisotropy, the opposite of wild-type
holoenzyme. These results suggest that T286 autophosphor-
ylation is involved in the mechanism for extending cata-
lytic-domain pairs after activation and in maintaining the
paired state.FIGURE 4 CaMKII structural changes associated with CaMKIINtide
inhibitory peptide interactions. (A) Partial CaMKIINtide inhibition of
T286 autophosphorylation was detected by immunoblot analysis of
V-CaMKIIa. GFP and pT286 specific antibodies were used to probe paired
blots. FPFAwas used to monitor changes in holoenzyme (B) brightness, (C)
diffusion time, (D) steady-state anisotropy, and (E) time-resolved anisot-
ropy of V-CaMKIIa either alone, incubated with CaMKIINtide, or coincu-
2þCaMKIINtide triggers a decrease in catalytic-
domain homo-FRET
CaMKIINtide is a peptide derived from the brain-specific
CaMKIIN proteins (45–47). CaMKIINtide interacts with
T-sites of the activated kinase but only partially inhibits
T286 autophosphorylation (45,47). A T286 autophosphory-
lation assay was used to confirm that CaMKIINtide interacts
with, and partially inhibits V-CaMKIIa (Fig. 4 A). High
concentrations of CaMKIINtide resulted in a reduction in
the holoenzyme brightness consistent with the loss of two
subunits (Fig. 4 B, ANOVA, P < 0.0002). Ca2þ/CaM was
not required for this reduction indicating that subunit loss
was not mediated by a T-site interaction. Increases in both
diffusion time (Fig. 4 C) and anisotropy (Fig. 4, D and E)
were observed when Ca2þ/CaM and CaMKIINtide were
added together. Of these, only the change in diffusion
time was observed with Ca2þ/CaM alone (Fig. 2, B
and C). In contrast, the large increase in anisotropy was
only observed when both Ca2þ/CaM and CaMKIINtide
were added. This alteration was highly significant (ANOVA,
P < 0.0001, Tukey’s multiple comparisons test); indicative
of a genuine T-site-mediated conformational change.
Steady-state anisotropy was next measured as a function
of CaMKIINtide concentration to explore the possibility
that T-sites on paired catalytic-domains interact coopera-
tively with exogenous ligand. The addition of CaMKIINtide
with excess CaM yielded an anisotropy dose-response curve
with an EC50 of 186 nM and a Hill coefficient of 2.75 0.7
(n¼ 4) (Fig. 4 F), suggesting that catalytic-domain pair sep-
aration is coordinated by cooperative T-site interactions
(13,18).bated with Ca /CaM and CaMKIINtide. Bars represent mean values. (F)
Dose response of V-CaMKIIa steady-state anisotropy incubated with
limited concentrations of CaMKIINtide in the presence of Ca2þ/CaM.
Data are plotted as mean5 SD. Solid line represents a fitting curvewhereas
dashed lines represent the mean steady-state anisotropy of V17Vand V32V
homo-FRET standards. To see this figure in color, go online.T-sites regulate catalytic-domain pairing
V-CaMKIIa(I205K) was used to test if T-site mutations per-
turb catalytic-domain pairing. I205K blocks holoenzyme in-
teractions with NMDA receptors (13,16), microtubules (48),
and translocation (16). V-CaMKIIa(I205K) holoenzyme
brightness (Fig. 5 A) was similar to wild-type, but
CaMKIINtide triggered subunit loss was no longer observed
(compare Figs. 4 B and 5 A). V-CaMKIIa(I205K) diffusion
time was higher than autoinhibited V-CaMKIIa (ANOVA,
P ¼ 0.005), but activation, with or without CaMKIINtide,
increased diffusion time to values similar to the activated
holoenzyme (compare Figs. 5 B and 2 B). The steady-Biophysical Journal 108(9) 2158–2170state anisotropy of V-CaMKIIa(I205K) (Fig. 5 C) was
0.283 5 0.005 (n ¼ 4), slightly higher than autoinhibited
V-CaMKIIa (0.273 5 0.007, n ¼ 3, data not shown).
Surprisingly Ca2þ/CaM decreased V-CaMKIIa(I205K)
anisotropy (ANOVA, P ¼ 0.0129; Fig. 5 C), and initiated
attenuated T286 autophosphorylation (see Fig. 5, D
and E). The addition of CaMKIINtide to activated
V-CaMKIIa(I205K), in contrast to wild-type V-CaMKIIa
FIGURE 5 The I205K T-site mutation stabilizes catalytic-domain pair-
ing. FPFAwas used to monitor changes in V-CaMKIIa(I205K) (A) bright-
ness, (B) diffusion time, and (C) steady-state anisotropy either alone,
activated with Ca2þ/CaM, or coincubated with Ca2þ/CaM and
CaMKIINtide. Bars represent the mean. Immunoblots of V-CaMKIIa and
V-CaMKIIa(I205K) either alone or incubated with Ca2þ/CaM probed by
(D) CaMKIIa antibody or (E) pT286 antibody was used to confirm activa-
tion of V-CaMKIIa(I205K) holoenzyme. (F) The I205K mutation trans-
forms a monomeric version of CaMKIIa into a dimer. The brightness of
V-CaMKIIa holoenzyme, V-CaMKIIa(D344) (a monomeric CaMKIIa
deletion mutant lacking the oligomerization domain), and V-CaMKIIa
(I205K/D344) (the same deletion mutant but having the I205K mutation)
are plotted. Venus monomer and dimer (V17V) are also plotted for compar-
ison. Bars represent the means with n ¼ 5, 15, 20, 13, and 6 for those
samples, respectively. To see this figure in color, go online.
Structural Changes in CaMKII Holoenzyme 2165(see Fig. 4, D–F), did not modify the already-decreased
anisotropy (Fig. 5 C). These experiments suggest that the
I205K mutation alters catalytic-domain pairing and exten-
sion before activation, reinforces pairing afterward, as
well as prevents T-site binding of the inhibitor peptide.Brightness analysis of oligomerization-domain deletion
mutants of V-CaMKIIa and V-CaMKIIa(I205K) were
used to test if I205K promotes catalytic-domain pairing.
Intact holoenzyme, monomeric, and dimeric Venus were
used as controls. The brightness of V-CaMKIIa(D344), a
deletion mutant that no longer has its association domain
and hence should be monomeric, was statistically indistin-
guishable from monomeric Venus (ANOVA, P < 0.0001,
Tukey’s multiple comparison test), and was one-tenth the
brightness (0.10 5 0.02, mean 5 propagated SD) of the
V-CaMKIIa holoenzyme (Fig. 5 F). V-CaMKIIa(I205K/
D344) was approximately twice as bright as V-CaMKIIa
(D344) (1.9 5 0.5). Its brightness was different than the
monomeric Venus, but was statistically indistinguishable
from the dimeric Venus control, indicating that a single
T-site point mutation can directly support the formation of
catalytic-domain pairs at nanomolar concentrations.
Does kinase activation directly trigger catalytic-domain
separation in living cells, or, as predicted by these in vitro
FPFA experiments, are subsequent T-site interactions
required? V-CaMKIIa was expressed in HEK-293 cells
either alone, cotransfected with calmodulin, or with both
calmodulin and CaMKIIN. Steady-state anisotropy was
measured using two-photon scanning-microscopy before
and after calcium ionophore treatment (Fig. 6 A). Before
ionomycin treatment, the V-CaMKIIa steady-state anisot-
ropy was 0.219 5 0.003 for cells expressing V-CaMKIIa
alone (n ¼ 10 cells), 0.218 5 0.004 (n ¼ 10) for cells ex-
pressing V-CaMKIIa and calmodulin, and 0.219 5 0.003
(n ¼ 10) for cells expressing V-CaMKIIa with calmodulin
and CaMKIIN. Ionomycin treatment did not alter the
V-CaMKIIa anisotropy when expressed alone (0.219 5
0.004, n ¼ 8) or with calmodulin (0.217 5 0.006, n ¼ 8).
A statistically significant rise in anisotropy was observed
for cells transfected with V-CaMKIIa, calmodulin and
CaMKIIN (0.248 5 0.019, n ¼ 10) as determined by
ANOVA (P < 0.0001). Images of cells transfected with
V-CaMKIIa, calmodulin and CaMKIIN before and after
ionomycin treatment are shown in Fig. 6 B. V-CaMKIIa
expression levels varied from cell to cell (Fig. 6 B, left
panels), as did V-CaMKIIa anisotropy values (see Fig. 6,
A and B, right panels) but within individual cells the distri-
bution of anisotropy values appeared homogenous. Further-
more, the increase in anisotropy (compare Fig. 6 B, right
top and bottom panels) observed with ionomycin treatment
was not correlated with cells expressing lower levels of
V-CaMKIIa.DISCUSSION
FPFA measurements revealed that the primary structural
change that occurs with CaMKIIa activation was a large in-
crease in holoenzyme hydrodynamic volume (Fig. 2 B).
Based on FRET (38,39,49) and small-angle x-ray scattering
measurements (37), this increase is interpreted as a lateralBiophysical Journal 108(9) 2158–2170
FIGURE 6 V-CaMKIIa activation triggers cata-
lytic domain separation in HEK cells if a T-site
ligand is coexpressed. (A) Steady-state anisotropy
of V-CaMKIIa expressed in HEK-293 cells was
monitored when expressed either alone, cotrans-
fected with CaM, or with both CaM and CaMKIIN
both before and after calcium ionophore treatment.
Data were collected from regions of interest in
cytoplasm. Bars represent the means of 10 cells.
Steady-state anisotropy of Venus monomer and
dimer (V17V) expressed in HEK-293 cells
are plotted for comparison. (B) Representative
fluorescence intensity and anisotropy images
of V-CaMKIIa cotransfected with CaM and
CaMKIIN in HEK-293 cells before and after iono-
mycin treatment. (C) Model to explain structural
changes of a catalytic domain pair on binding
CaM either with or without ATP, or with CaM,
ATP, and CaMKIINtide. Model key: oligomeriza-
tion domains (red and gray hexagons), Catalytic
domain (blue ovals), Venus fluorophore (yellow
rectangles), Ca2þ/CaM (green circles), and
CaMKIINtide (orange ovals). Black double-
headed arrows indicate homo-FRET between
Venus molecules in close proximity. To see this
figure in color, go online.
2166 Nguyen et al.extension of catalytic-domains away from the central
oligomerization-domain core. Catalytic-domain extension
occurred without any detectable change in homo-FRET be-
tween Venus-tagged catalytic-domains (Fig. 2, C and D)
indicating that catalytic-domain pairing was maintained
both before and after kinase activation.
Ca2þ/CaM dependent changes in the holoenzyme hydro-
dynamic volume were mirrored by changes in the extent of
T286 autophosphorylation (Fig. 3 C), confirming activation
and suggesting that the extension of catalytic-domain pairs
is closely linked to T286 autophosphorylation. Three exper-
imental manipulations were used to test this hypothesis:
removing ATP, mutating lysine 42 to an arginine (K42R)
to block kinase catalytic activity, and mutating threonine
286 to an alanine (T286A) to remove the T286 autophos-
phorylation substrate. All three perturbations resulted in
attenuated catalytic-domain extension (Fig. 3 F). These
same manipulations also resulted in decreases in the
homo-FRET between Venus-tagged catalytic-domains
(Fig. 3 E). Care must be exercised when interpreting
FRET changes (50–52), as a reduction might reflect a
change in fluorophore orientation rather than proximity
(53,54). Because Venus was attached to the catalytic-
domain via a flexible 15 amino-acid linker in all CaMKIIBiophysical Journal 108(9) 2158–2170constructs used in this study, these changes most likely
reflect an increase in separation. A small reduction in
homo-FRET was also observed for the wild-type holoen-
zyme at limiting Ca2þ/CaM concentrations (Fig. 3 B). Base-
line homo-FRET signal was restored at saturating Ca2þ/
CaM concentrations where maximal T286 autophosphoryla-
tion was achieved (see Fig. 3, B and C). The magnitude of
this biphasic homo-FRET change was similar to the differ-
ence in FRET observed between two homo-FRET dimeric
standards, V17V and V32V (Fig. 3 B). The FRET effi-
ciencies of two structurally related hetero-FRET standards,
C17Vand C32V indicate that the difference in separation for
these constructs corresponds to a change of ~4 A˚ (54). We
conclude that these changes reflect subtle and previously
covert transformations in the nature of catalytic-domain
pairing in response to Ca2þ/CaM binding and subsequent
T286 autophosphorylation. A cartoon depicting one plau-
sible structural model to explain both a biphasic change in
homo-FRET and a monotonic change in hydrodynamic vol-
ume is shown in Fig. 6 C.
FPFA revealed two structural changes in the CaMKII ho-
loenzyme triggered by the T-site ligandCaMKIINtide: disso-
ciation of catalytic-domain pairs, detected as an increase in
anisotropy (decrease in homo-FRET; Fig. 4, D–F), and the
Structural Changes in CaMKII Holoenzyme 2167loss of ~two subunits from the holoenzyme, detected as a
decrease in brightness (Fig. 4 B). It is unlikely that the loss
of subunits from the holoenzyme was triggered by T-site in-
teractions because the addition of Ca2þ/CaM was not
required (Fig. 4 B). We speculate that at high concentrations
CaMKIINtide might interact with an additional site on the
holoenzyme, such as the putative peptide-binding pocket in
the association domain (37). In contrast, the anisotropy
change observed in wild-type holoenzyme was only
observed in response to the addition of both Ca2þ/CaM
andCaMKIINtide, indicating that catalytic-domain pair sep-
aration is likely the result of T-site interaction (Fig. 6 C).
Furthermore, the EC50 for catalytic-domain separation
(186 nM, Fig. 4 F) is comparable to the CaMKIINtide
IC50 (100 to 400 nM) for specific CaMKII inhibitory activity
(45), suggesting that these mechanisms share the same bind-
ing site.
Catalytic-domain pairing in primary cultures of hippo-
campal neurons expressing V-CaMKIIa was previously
observed, and calcium influx through NMDA receptors re-
sulted in a decrease in FRET (38). Because hippocampal
neurons should have an abundance of T-site ligands it was
not clear if catalytic-domain pair separation resulted directly
from Ca2þ/CaM binding, or from subsequent T-site interac-
tions. We tested if Ca2þ/CaM alone can trigger a decrease in
V-CaMKIIa homo-FRET in HEK cells, or if a T-site ligand
was required. In both intact HEK cells (Fig. 6, A and B), as
well as in HEK cell homogenates in vitro (Fig. 4), catalytic-
domain separation was only observed when Ca2þ/CaM acti-
vated V-CaMKIIa in the presence of exogenous T-site
ligand. Thus, it is likely that the catalytic-domain pair sep-
aration previously observed in hippocampal neurons arose
from subsequent T-site interactions.
The ability of CaMKIINtide to trigger catalytic-domain
pair separation suggests that T-sites might play a role in
maintaining catalytic-domain pairing. If true, the T-site mu-
tation I205K, known to interfere with NMDA receptor inter-
actions (16), translocation onto microtubules (48), and the
formation of interholoenzyme clusters (25), might also per-
turb catalytic-domain pairing. The introduction of I205K
did not alter the brightness of autoinhibited CaMKIIa
(Fig. 5 A), but its diffusion time (compare Figs. 5 B and
2 B) and anisotropy was higher than wild-type (compare
Figs. 5 C and 2 C), suggesting alterations in both pairing
and catalytic-domain regulatory-domain interactions. The
impact of I205K was further tested by brightness analysis
of oligomerization-domain deletion mutants. Free of the
holoenzyme context, I205K stabilized catalytic-domain
pairing (Fig. 5 F). Similarly, in the intact holoenzyme,
the addition of Ca2þ/CaM also increased homo-FRET
(Fig. 5 C), along with the expected increase in hydrody-
namic volume (Fig. 5 B), indicating that the full extension
of I205K catalytic-domains results in the stabilization of
catalytic-domain pairs. This is supported by the observation
that CaMKIINtide could not trigger I205K catalytic-domainseparation (compare Figs. 5 C and 4 D), even though Ca2þ/
CaM triggered T286 autophosphorylation (albeit attenu-
ated; see Fig. 5, D and E). Compared with the wild-type
holoenzyme, these experiments indicate that in the context
of the intact holoenzyme, catalytic-domain pairing was
weakened in the autoinhibited state and stabilized in the
activated state.
Mice expressing CaMKIIa(T286A) lacked NMDA recep-
tor-dependent long-term potentiation (LTP) and had deficits
in spatial learning (55), suggesting that T286 autophosphor-
ylation is required for LTP. Remarkably, activity triggered
translocation into spines, another holoenzyme feature
thought to be essential for LTP (19,56), occurred with the
T286A mutation (16). Is there a structural basis for this
apparent paradox? The diffusion coefficient for T286A
dropped over the full range of Ca2þ/CaM concentrations
tested (Fig. 3 F). Two other perturbations that blocked
T286 autophosphorylation also blocked full catalytic-
domain extension (Fig. 3 F). Wild-type holoenzyme had a
biphasic anisotropy dose-response to CaM whereas T286A
had a large monophasic increase (Fig. 3 E). The magnitude
of this increase was comparable with the anisotropy change
observed in wild-type V-CaMKIIa in response to Ca2þ/
CaM and CaMKIINtide (see Fig. 4 F). Thus T286A allows
Ca2þ/CaM alone to trigger catalytic-domain separation. We
hypothesize that the ability of a holoenzyme to translocate
into spines correlates with the ability of its catalytic-domain
pairs to separate. In contrast, the inability to extend cata-
lytic-domains with activation seems to correlate with defi-
cits in LTP and spatial learning.
Morris and To¨ro¨k proposed that 12 catalytic-domains in
the CaMKII holoenzyme are organized as six pairs with
C6 point-group symmetry around a central core of oligo-
merization domains (57). With this configuration, they
argued, T286 autophosphorylation should occur between
catalytic-domains oriented head-to-head, and thus the coop-
erative unit would be catalytic-domain pairs. Experimental
support for autoinhibited catalytic-domains organized as
pairs came first from Hill coefficient for T286 autophos-
phorylation revealing cooperativity between two subunits
(30). X-ray analysis of isolated catalytic-domains (37),
homo- and hetero-FRET experiments (38,39), and analyt-
ical-ultracentrifugation (7) all added support for a paired
organization, but the structural basis for pairing is not
known. Kuriyan and colleagues proposed pairing via
regulatory-domain coiled-coil interactions (37). Knapp
and colleagues, however, disputed this model because this
interaction was not observed in human CaMKII oligomeri-
zation-domain deletion mutants, and because regulatory-
domain peptides, derived from the putative coiled-coil
region, did not disrupt pairing (7). The observation that acti-
vation did not alter the proximity between Venus-tagged cat-
alytic-domain pairs (Fig. 2, C and D) also argues against the
coiled-coil model. Based on structural changes that are
observed in the holoenzyme after activation we proposeBiophysical Journal 108(9) 2158–2170
2168 Nguyen et al.an alternative model, that interactions between T-sites and
T286 facilitate catalytic-domain pairing before activation,
whereas interactions between phosphorylated-T286 and
T-sites on extended catalytic-domains mediate pairing after
activation (Fig. 6 C). This model is based on the following
observations: 1) both Ca2þ/CaM and a T-site ligand are
needed for catalytic-domain separation (Figs. 4 and 6, A
and B); and 2) mutating T286 to an alanine increased the
anisotropy signal in the absence of Ca2þ/CaM, and unlike
wild-type holoenzyme, catalytic-domain pairs separate on
activation (Fig. 3 E). In contrast, removing ATP or intro-
ducing the K42R mutation (catalytic activity negative) did
not disrupt catalytic-domain pairing in the absence of
Ca2þ/CaM, but did after Ca2þ/CaM activation (Fig. 3 E);
and 3) like T286A, the introduction of the I205K mutation
in the T-site also caused a small increase in anisotropy
before adding Ca2þ/CaM (compare Figs. 5 D and 2 C).
A model for the intact autoinhibited CaMKII holoen-
zyme has been recently proposed (40). This structure is a
compact dodecamer with catalytic-domains arranged as
monomers distributed around and docked to a central asso-
ciation domain core. As this structure does not contain cat-
alytic-domain pairs, it raises key questions about how
catalytic-domain pairs form, as well as questions about
the model’s general applicability. For example, the muta-
tion introduced to enable crystallization may have altered
the holoenzyme structure, or the structure of the mutated
b7-isoform may not characterize more representative iso-
forms (such as CaMKIIa). Furthermore, the b7-isoform,
whose structure is based on an mRNA splice variant,
may not actually be expressed under normal physiolog-
ical conditions. One surprising aspect of the compact
CaMKIIb7 holoenzyme structure is that CaM binding sites
on regulatory domains are not accessible (40). Thus if this
structure is physiologically relevant, an additional extended
structure for an autoinhibited holoenzyme must also exist
(40). Our FPFA data support the existence of this postu-
lated, Ca2þ/CaM accessible, and autoinhibited holoenzyme
structure, but with catalytic-domains organized as pairs
(Fig. 6 C, left). Presumably, when monomeric catalytic-
domains undock from the association domain core they
reorganize to form dimers. Our data also support the pro-
posed extension of this structure on binding Ca2þ/CaM
(40) (Fig. 6 C, center panels).
FPFA has revealed previously covert changes in CaMKII
holoenzyme organization associated with activation and
subsequent T286 autophosphorylation and T-site interac-
tions. Catalytic-domain pairs were observed both before
and after activation. The maintenance of catalytic-domain
pairs through Ca2þ/CaM triggered activation appears to
involve a subtle conformational change as revealed by
homo-FRET measurements (Fig. 3 E) and T286 autophos-
phorylation (Fig. 3 C). The dimeric suborganization of the
autoinhibited holoenzyme is consistent with cooperative
Ca2þ/CaM binding to the holoenzyme (Hill coefficients ofBiophysical Journal 108(9) 2158–21701.6 5 0.5; Fig. 1 B). Similarly, the modified dimeric orga-
nization after activation and T286 autophosphorylation is
consistent with the holoenzyme’s cooperative interaction
with the T-site ligand CaMKIINtide (Hill coefficients of
2.7 5 0.7; Fig. 4 F). Wild-type CaMKII holoenzyme can
interact with the NR2B subunit of NMDA receptor to
mediate translocation of the holoenzyme into synaptic
spines (16,18,19,23). In contrast, a monomeric CaMKII
deletion mutant lacking the oligomerization domain
failed to interact with the NMDA receptor, and also failed
to translocate into spines, despite having an unaltered
T-site (13,18). Since NR2B, like CaMKIINtide, and the
CaMKIIN-protein all interact with CaMKII via T-site inter-
action (13,47), and we have shown that both CaMKIINtide
as well as the CaMKIIN protein can trigger the separation of
catalytic-domain pairs in the activated holoenzyme (Figs. 4,
D–F, and 6 A), we speculate that establishing an interaction
between an activated CaMKII holoenzyme and an NMDA
receptor involves replacing less-stable T-site interactions
between the two catalytic-domains comprising a pair, with
more stable T-site interactions between the same two cata-
lytic-domains and two NMDA receptor subunits. Such an
exchange mechanism would readily explain why a mono-
meric CaMKII subunit would not be able to effectively
bind to the NMDA receptor, and would also explain why
the T-site I205K mutation, which we have shown stabilizes
catalytic-domain pair interactions in the activated state
(Fig. 5), has attenuated binding to NR2B subunits and there-
fore reduced translocation into synapses.SUPPORTING MATERIAL
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